General Information of DTT (ID: TTJFOAL)

DTT Name Wee1-like protein kinase (WEE1) DTT Info
Gene Name WEE1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
MK-1775 DM3WDZ5 Ovarian cancer 2C73 Phase 2 [1]
ZN-c3 DM4MSLY Uterine serous carcinoma 2C72.1 Phase 2 [2]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione DMGCX7E Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth. Oncol Rep. 2013 May;29(5):2011-8.
2 Clinical pipeline report, company report or official report of Zentalis Pharmaceuticals.
3 Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors. Eur J Med Chem. 2009 Apr;44(4):1383-95.